Universe Pharmaceuticals (UPC) Invested Capital (2020 - 2025)
Universe Pharmaceuticals' Invested Capital history spans 6 years, with the latest figure at $58.2 billion for Q3 2025.
- On a quarterly basis, Invested Capital rose 13.39% to $58.2 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $58.2 billion, a 13.39% increase, with the full-year FY2025 number at $58.2 billion, up 13.39% from a year prior.
- Invested Capital hit $58.2 billion in Q3 2025 for Universe Pharmaceuticals, up from $51.4 billion in the prior quarter.
- Over the last five years, Invested Capital for UPC hit a ceiling of $58.2 billion in Q3 2025 and a floor of $32.3 million in Q1 2024.
- Historically, Invested Capital has averaged $21.6 billion across 5 years, with a median of $14.0 billion in 2022.
- Biggest five-year swings in Invested Capital: plummeted 100.0% in 2021 and later skyrocketed 75059.29% in 2022.
- Tracing UPC's Invested Capital over 5 years: stood at $47.0 million in 2021, then skyrocketed by 75059.29% to $35.3 billion in 2022, then decreased by 20.82% to $28.0 billion in 2023, then soared by 83.59% to $51.4 billion in 2024, then increased by 13.39% to $58.2 billion in 2025.
- Business Quant data shows Invested Capital for UPC at $58.2 billion in Q3 2025, $51.4 billion in Q3 2024, and $32.3 million in Q1 2024.